Clinical Trials Directory

Trials / Completed

CompletedNCT03643263

Exhaled Breath Condensate Assessment in Stable Non-Cystic Fibrotic Bronchiectasis

Exploring the Relationship Between pH of Exhaled Breath Condensate and Disease Severity as Well as Prognosis of Bronchiectasis

Status
Completed
Phase
Study type
Observational
Enrollment
121 (actual)
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The measurement of markers in the expired breath condensate has proven to be a useful method for assessing and monitoring airway inflammation. The aim of this study is to determine the amounts of pH in the expired breath condensate of patients with bronchiectasis, and the relationship between pH and the severity of bronchiectasis.

Detailed description

The aim of this study is to determine the amounts of pH in the expired breath condensate of patients with bronchiectasis, and the relationship between pH and the severity of bronchiectasis. Further clarify the link between EBC pH and the risk of future acute exacerbations, mortality and lung function decline through a one-year follow-up. Hoping to explore new validated biomarkers of the disease severity and progression in bronchiectasis. During the observation, EBC pH and other valid indicators will be measured when patients were enrolled.

Conditions

Timeline

Start date
2018-06-25
Primary completion
2020-07-02
Completion
2020-07-02
First posted
2018-08-22
Last updated
2022-07-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03643263. Inclusion in this directory is not an endorsement.

Exhaled Breath Condensate Assessment in Stable Non-Cystic Fibrotic Bronchiectasis (NCT03643263) · Clinical Trials Directory